Ars Pharmaceuticals, Inc. · NASDAQ:SPRY
Rubric Capital Management LP reported a 6.27% stake in Ars Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 13, 2026
Rubric Capital Management LP reported a 6.27% stake in Ars Pharmaceuticals, Inc., 6,200,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G).
- Stake
- 6.27%
- Shares
- 6,200,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Rubric Capital Management LP | 6.27% | 6,200,000 |
| David Rosen | 6.27% | 6,200,000 |
Source
Related
- Ars Pharmaceuticals, Inc.
- Rubric Capital Management LP
- Ars Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Rubric Capital Management LP · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 14, 2026
- Form 4 · Karas Eric · Jun 12, 2026
- Form 4 · Fitzpatrick Alexander A · Jun 12, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026